U.S., Sept. 25 -- ClinicalTrials.gov registry received information related to the study (NCT07837856) titled 'Therapeutic Adherence in Type 2 Diabetes' on Sept. 10.
Brief Summary: A quasi-experimental, non-randomized, prospective, longitudinal study comparing the use of WhatsApp messaging versus the SMART technique in patients with type 2 diabetes to improve treatment adherence
Study Start Date: Nov. 30, 2024
Study Type: INTERVENTIONAL
Condition:
Diabetes Mellitus, Type 2/Prevention & Control
Diabete Type 2
Treatment Adherence
Intervention:
OTHER: Group I (WhatsApp) motivational and educational messages delivered periodically
Positive reinforcement messages were sent once every two days for two weeks, then once a week for three week...